A critical role for type I IFN-dependent NK cell activation in innate immune elimination of adenoviral vectors in vivo

Molecular Therapy

Volumn 16, Issue 7, 2008, Pages 1300-1307

  Zhu, Jiangao ^a   Huang, Xiaopei ^a   Yang, Yiping ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DRUG ELIMINATION; GENE EXPRESSION REGULATION; GENE TARGETING; IMMUNOSTIMULATION; IN VIVO GENE TRANSFER; INNATE IMMUNITY; INTERFERON PRODUCTION; LYMPHOCYTE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE;

EID: 45749110171     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.88     Document Type: Article

References (40)

1. Wilson, JM (1996). Adenoviruses as gene-delivery vehicles. N Engl J Med 334: 1185-1187.
2. Tatsis, N and Ertl, HC (2004). Adenoviruses as vaccine vectors. Mol Ther 10: 616-629.
3. Barouch, DH and Nabel, GJ (2005). Adenovirus vector-based vaccines for human immunodeficiency virus type 1. Hum Gene Ther 16: 149-156.
4. Muruve, DA (2004). The innate immune response to adenovirus vectors. Hum Gene Ther 15: 1157-1166.
5. Hensley, SE and Amalfitano, A (2007). Toll-like receptors impact on safety and efficacy of gene transfer vectors. Mol Ther 15: 1417-1422.
6. Basner-Tschakarjan, E, Gaffal, E, O'Keeffe, M, Tarmo, D, Limmer, A, Wagner, H et al. (2006). Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-α production. J Gene Med 8: 1300-1306.
7. Iacobelli-Martinez, M and Nemerow, GR (2007). Preferential activation of Toll-like receptor nine by CD46-utilizing adenoviruses. J Virol 81: 1305-1312.
8. Hartman, ZC, Kiang, A, Everett, RS, Serra, D, Yang, XY, Clay, TM et al. (2007). Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo. J Virol 81: 1796-1812.
9. Zhu, J, Huang, X and Yang, Y (2007). Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways. J Virol 81: 3170-3180.
10. Cerullo, V, Seiler, MP, Mane, V, Brunetti-Pierri, N, Clarke, C, Bertin, TK et al. (2007). Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors. Mol Ther 15 378-385.
11. + T cell induction, is dependent on type IIFN signaling during vaccination with adenovirus vectors. J Immunol 175: 6032-6041.
12. Nociari, M, Ocheretina, O, Schoggins, JW and Falck-Pedersen, E (2007). Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator. J Virol 81: 4145-4157.
13. Pestka, S, Krause, CD and Walter, MR (2004). Interferons, interferon-like cytokines, and their receptors. Immunol Rev 202 8-32.
14. García-Sastre, A and Biron, CA (2006). Type 1 interferons and the virus-host relationship: A lesson in détente. Science 312 879-882.
15. Müller, U, Steinhoff, U, Reis, LF, Hemmi, S, Pavlovic, J, Zinkernagel, RM et al. (1994). Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921.
16. van den Broek, MF, Müller, U, Huang, S, Zinkernagel, RM and Aguet, M (1995). Immune defence in mice lacking type I and/or type II interferon receptors. Immunol Rev 148: 5-18.
17. Hensley, SE, Cun, AS, Giles-Davis, W, Li, Y, Xiang, Z, Lasaro, MO et al. (2007). Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector. Mol Ther 15: 393-403.
18. Biron, CA, Nguyen, KB, Pien, GC, Cousens, LP and Salazar-Mather, TP (1999). Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu Rev Immunol 17: 189-220.
19. Theofilopoulos, AN, Baccala, R, Beutler, B and Kono, DH (2005). Type I interferons (α/β) in immunity and autoimmunity. Annu Rev Immunol 23: 307-336.
20. Liu, ZX, Govindarajan, S, Okamoto, S and Dennert, G (2000). NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection. J Immunol 164: 6480-6486.
21. Peng, Y, Falck-Pedersen, E and Elkon, KB (2001). Variation in adenovirus transgene expression between BALB/c and C57BL/6 mice is associated with differences in interleukin-12 and γ interferon production and NK cell activation. J Virol 75: 4540-4550.
22. Worgall, S, Wolff, G, Falck-Pedersen, E and Crystal, RG (1997). Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum Gene Ther 8: 37-44.
23. Wolff, G, Worgall, S, van Rooijen, N, Song, WR, Harvey, BG and Crystal, RG (1997). Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ. J Virol 71: 624-629.
24. Lieber, A, He, CY, Meuse, L, Schowalter, D, Kirillova, I, Winther, B et al. (1997). The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J Virol 71: 8798-8807.
25. French, AR and Yokoyama, WM (2003). Natural killer cells and viral infections. Curr Opin Immunol 15: 45-51.
26. Brown, MG, Dokun, AO, Heusel, JW, Smith, HR, Beckman, DL, Blattenberger, EA et al. (2001). Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292: 934-937.
27. Arase, H, Mocarski, ES, Campbell, AE, Hill, AB and Lanier, LL (2002). Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296b: 1323-1326.
28. Andoniou, CE, van Dommelen, SL, Voigt, V, Andrews, DM, Brizard, G, Asselin-Paturel, C et al. (2005). Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat Immunol 6: 1011-1019.
29. Nguyen, KB, Salazar-Mather, TP, Dalod, MY, Van Deusen, JB, Wei, XQ Liew, FY et al. (2002). Coordinated and distinct roles for IFN-α β, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 169: 4279-4287.
30. Lucas, M, Schachterle, W, Obede, K, Aichele, P and Diefenbach, A (2007). Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26: 503-517.
31. He, TC, Zhou, S, da Costa, LT, Yu, J, Kinzler, KW and Vogelstein, B (1998). A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95: 2509-2514.
32. Yang, Y, Ertl, HC and Wilson, JM (1994). MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1 433-442.
33. Graham, FL, Smiley, J, Russell, WC and Naim, R (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59-74.
34. Yang, Y, Huang, CT, Huang, X and Pardoll, DM (2004). Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat Immunol 5: 508-515.
35. Zhu, J, Martinez, J, Huang, X and Yang, Y (2007). Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-β. Blood 109: 619-625.
36. Zompi, S, Hamerman, JA, Ogasawara, K, Schweighoffer, E, Tybulewicz, VL, Di Santa, JP et al. (2003). NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nat Immunol 4: 565-572.
37. Orange, JS, Wang, B, Terhorst C and Biron, CA (1995). Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 182: 1045-1056.
38. Winkler-Pickett, R, Young, HA, Cherry, JM, Diehl, J, Wine, J, Back, T et al. (2008). In vivo regulation of experimental autoimmune encephalomyelitis by NK cells: Alteration of primary adaptive responses. J Immunol 180: 4495-4506.
39. Yang, Y, Nunes, FA, Berencsi, K, Furth, EE, Gönczöl, E and Wlson, JM (1994). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 91: 4407-4411.
40. Everett, RS, Hodges, BL, Ding, EY, Xu, F, Serra, D and Amalfitano, A (2003). Liver toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectors. Hum Gene Ther 14: 1715-1726.